JP2022539185A5 - - Google Patents

Info

Publication number
JP2022539185A5
JP2022539185A5 JP2021577642A JP2021577642A JP2022539185A5 JP 2022539185 A5 JP2022539185 A5 JP 2022539185A5 JP 2021577642 A JP2021577642 A JP 2021577642A JP 2021577642 A JP2021577642 A JP 2021577642A JP 2022539185 A5 JP2022539185 A5 JP 2022539185A5
Authority
JP
Japan
Prior art keywords
composition according
nootropic
acid
compound
nootropic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577642A
Other languages
English (en)
Japanese (ja)
Other versions
JP7686581B2 (ja
JP2022539185A (ja
Filing date
Publication date
Priority claimed from GBGB1909454.9A external-priority patent/GB201909454D0/en
Application filed filed Critical
Publication of JP2022539185A publication Critical patent/JP2022539185A/ja
Publication of JP2022539185A5 publication Critical patent/JP2022539185A5/ja
Application granted granted Critical
Publication of JP7686581B2 publication Critical patent/JP7686581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577642A 2019-07-01 2020-06-29 認知機能の向上薬としてのメチルチオニニウム Active JP7686581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1909454.9A GB201909454D0 (en) 2019-07-01 2019-07-01 Enhancers
GB1909454.9 2019-07-01
PCT/EP2020/068229 WO2021001306A1 (en) 2019-07-01 2020-06-29 Methylthioninium as enhancers of the cognitive function

Publications (3)

Publication Number Publication Date
JP2022539185A JP2022539185A (ja) 2022-09-07
JP2022539185A5 true JP2022539185A5 (cg-RX-API-DMAC7.html) 2023-07-07
JP7686581B2 JP7686581B2 (ja) 2025-06-02

Family

ID=67539959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577642A Active JP7686581B2 (ja) 2019-07-01 2020-06-29 認知機能の向上薬としてのメチルチオニニウム

Country Status (12)

Country Link
US (1) US20220330594A1 (cg-RX-API-DMAC7.html)
EP (1) EP3989977A1 (cg-RX-API-DMAC7.html)
JP (1) JP7686581B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220028045A (cg-RX-API-DMAC7.html)
CN (1) CN114096254A (cg-RX-API-DMAC7.html)
AU (1) AU2020298737B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021025330A2 (cg-RX-API-DMAC7.html)
CA (1) CA3143417A1 (cg-RX-API-DMAC7.html)
GB (1) GB201909454D0 (cg-RX-API-DMAC7.html)
IL (1) IL289341A (cg-RX-API-DMAC7.html)
MX (1) MX428499B (cg-RX-API-DMAC7.html)
WO (1) WO2021001306A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY162313A (en) 2006-07-11 2017-05-31 Wista Lab Ltd Methods of synthesis and/or purification of diaminophenothiazinium compounds
BR112021000802A2 (pt) 2018-07-26 2021-04-13 Wista Laboratories Ltd. Dosagem otimizada de diaminofenotiazinas em populações
KR102856378B1 (ko) 2022-09-30 2025-09-08 주식회사 젬백스앤카엘 4r 타우병증의 치료 또는 예방용 펩티드
KR20250154422A (ko) 2023-03-03 2025-10-28 타우알엑스 쎄라퓨틱스 매니지먼트 리미티드 미세혈관 뇌질환 치료를 위한 디아미노페노티아진
KR20240176447A (ko) 2023-06-15 2024-12-24 주식회사 젬백스앤카엘 신규 펩티드 및 이의 용도
KR102800994B1 (ko) 2023-11-06 2025-04-29 주식회사 엘지에너지솔루션 무음극 코팅층 및 이를 포함하는 전고체 전지

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
CN104119294B (zh) 2006-03-29 2018-10-30 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物的制备方法
AU2008265045B2 (en) * 2007-06-19 2014-02-27 Taurx Therapeutics Management Ltd. Phenothiazine compounds for treating Mild Cognitive Impairment
PT2954932T (pt) 2007-10-03 2018-12-12 Wista Lab Ltd Utilização terapêutica de diaminofenotiazinas
KR101888713B1 (ko) 2011-02-11 2018-08-14 위스타 레보레이토리스 리미티드 페노티아진 디아미늄 염 및 이의 용도
EP2705841A1 (en) 2012-09-05 2014-03-12 Pharnext Combinations of nootropic agents for treating cognitive dysfunctions
PL3487505T3 (pl) 2016-07-25 2023-10-09 Wista Laboratories Ltd. Podawanie i dawkowanie diaminofenotiazyn
GB201614834D0 (en) * 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia

Similar Documents

Publication Publication Date Title
AU2020203101B9 (en) Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability
JP2020519661A5 (cg-RX-API-DMAC7.html)
US11786496B2 (en) Composition and methods for treating intestinal hyperpermeability
JP2022545005A5 (cg-RX-API-DMAC7.html)
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
ES2698363T3 (es) Composiciones de oxprenolol para tratar el cáncer
JP2009525265A5 (cg-RX-API-DMAC7.html)
JP2023546565A5 (cg-RX-API-DMAC7.html)
JPWO2023054732A5 (cg-RX-API-DMAC7.html)
KR20120050473A (ko) 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도
KR20160067225A (ko) 암 환자에서 근육 소모를 치료하는 선택적 안드로겐 수용체 조절물질 및 화학치료제
JP2022538642A5 (cg-RX-API-DMAC7.html)
TW201902474A (zh) 用於治療中風及減少神經損傷的化合物及其用途
RU2006141647A (ru) Производные феноксиалкилкарбоновых кислот при лечении воспалительных заболеваний
JP2002534379A5 (cg-RX-API-DMAC7.html)
CN103002893B (zh) 神经障碍性疼痛的治疗药或预防药
RU2017134553A (ru) Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов, и их применение
JP2023504166A (ja) 疼痛の治療のためのKv7カリウムチャネル開口薬の使用
JP2023512093A (ja) コロナウイルス感染の治療における4-アミノキノリン化合物の使用
JP2021091608A5 (cg-RX-API-DMAC7.html)
WO2023066330A1 (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
CN107789354A (zh) 预防和治疗抑郁症的化合物及其应用
KR20230012514A (ko) 치료방법
KR20230012515A (ko) 유익한 치료방법